Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial
2014; Nature Portfolio; Volume: 24; Issue: 1 Linguagem: Inglês
10.1038/npjpcrm.2014.3
ISSN2055-1010
AutoresThierry Troosters, Frank C. Sciurba, Marc Decramer, Nikos M. Siafakas, Solomon S. Klioze, Santosh Sutradhar, Idelle M. Weisman, Carla Yunis,
Tópico(s)Respiratory and Cough-Related Research
ResumoThe benefits of pharmacotherapy with tiotropium HandiHaler 18 μg for patients with chronic obstructive pulmonary disease (COPD) have been previously demonstrated. However, few data exist regarding the treatment of moderate disease (Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II).
Referência(s)